Q1 2020 Affimed NV Earnings Call Transcript
Good day, and welcome to Affimed's First Quarter 2020 Financial Results and Corporate Update Conference Call. (Operator Instructions). As a reminder, today's conference is being recorded. I will now introduce your host for today's conference, Alexander Fudukidis, Head of Investor Relations at Affimed. Please go ahead.
Thank you, Bernard. I'd like to welcome and thank you all for joining us today for Affimed's first quarter 2020 financial results and operational progress. This morning, Affimed issued a press release, which is also posted on our website at www.affimed.com.
On the call today, we have with us Drs. Adi Hoess, our Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; and Arndt Schottelius, Chief Medical (sic) [Scientific] Officer; and Michael Wolf, Head of Finance. We are also joined by Dr. Wolfgang Fischer, Chief Operating Officer; and Ms. Denise Mueller, Chief Business Officer. They will all be available for the Q
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |